| Dr Joshua Tyler Harrison, PSYD | |
|
321 Mitchell Ave, Batesville, IN 47006-8909 | |
| (812) 934-6624 | |
| Not Available |
| Full Name | Dr Joshua Tyler Harrison |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 8 Years |
| Location | 321 Mitchell Ave, Batesville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477041317 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | P.07673 (Ohio) | Secondary |
| 103TH0100X | Psychologist - Health Service | 20043132A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Margaret Mary Community Hospital Inc | 5193714335 | 70 |
News Archive
A wide range of avoidable risk factors to health – ranging from air pollution to poor diets to unsafe water – account for a growing number of deaths and a significant amount of disease burden, according to a new analysis of 79 risks in 188 countries.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced commencement of operations on the initial phase of production at the Company's Fengxian facility. This new multi-purpose pharmaceutical development and cGMP manufacturing facility is located in Fengxian in the suburbs of Shanghai, China.
AOptix Technologies, Inc., a leading-edge developer of advanced iris biometrics products and long-distance wireless optical communications solutions, today announced that AOptix and Aware, Inc. will be demonstrating a prototype dual-factor iris and face biometrics system in the AOptix exhibition booth at the upcoming Biometrics Consortium Conference and Technology Expo. The event takes place in Tampa from September 21 to 23, 2010.
Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmaceutical companies, today announced its financial results for the second quarter ended June 30, 2009.
› Verified 5 days ago
| Entity Name | Margaret Mary Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558368449 PECOS PAC ID: 5193714335 Enrollment ID: O20040511001443 |
News Archive
A wide range of avoidable risk factors to health – ranging from air pollution to poor diets to unsafe water – account for a growing number of deaths and a significant amount of disease burden, according to a new analysis of 79 risks in 188 countries.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced commencement of operations on the initial phase of production at the Company's Fengxian facility. This new multi-purpose pharmaceutical development and cGMP manufacturing facility is located in Fengxian in the suburbs of Shanghai, China.
AOptix Technologies, Inc., a leading-edge developer of advanced iris biometrics products and long-distance wireless optical communications solutions, today announced that AOptix and Aware, Inc. will be demonstrating a prototype dual-factor iris and face biometrics system in the AOptix exhibition booth at the upcoming Biometrics Consortium Conference and Technology Expo. The event takes place in Tampa from September 21 to 23, 2010.
Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmaceutical companies, today announced its financial results for the second quarter ended June 30, 2009.
› Verified 5 days ago
| Entity Name | Margaret Mary Community Hospital Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1558368449 PECOS PAC ID: 5193714335 Enrollment ID: O20060126000200 |
News Archive
A wide range of avoidable risk factors to health – ranging from air pollution to poor diets to unsafe water – account for a growing number of deaths and a significant amount of disease burden, according to a new analysis of 79 risks in 188 countries.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced commencement of operations on the initial phase of production at the Company's Fengxian facility. This new multi-purpose pharmaceutical development and cGMP manufacturing facility is located in Fengxian in the suburbs of Shanghai, China.
AOptix Technologies, Inc., a leading-edge developer of advanced iris biometrics products and long-distance wireless optical communications solutions, today announced that AOptix and Aware, Inc. will be demonstrating a prototype dual-factor iris and face biometrics system in the AOptix exhibition booth at the upcoming Biometrics Consortium Conference and Technology Expo. The event takes place in Tampa from September 21 to 23, 2010.
Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmaceutical companies, today announced its financial results for the second quarter ended June 30, 2009.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua Tyler Harrison, PSYD Po Box 223, Batesville, IN 47006-0223 Ph: (812) 933-5441 | Dr Joshua Tyler Harrison, PSYD 321 Mitchell Ave, Batesville, IN 47006-8909 Ph: (812) 934-6624 |
News Archive
A wide range of avoidable risk factors to health – ranging from air pollution to poor diets to unsafe water – account for a growing number of deaths and a significant amount of disease burden, according to a new analysis of 79 risks in 188 countries.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced commencement of operations on the initial phase of production at the Company's Fengxian facility. This new multi-purpose pharmaceutical development and cGMP manufacturing facility is located in Fengxian in the suburbs of Shanghai, China.
AOptix Technologies, Inc., a leading-edge developer of advanced iris biometrics products and long-distance wireless optical communications solutions, today announced that AOptix and Aware, Inc. will be demonstrating a prototype dual-factor iris and face biometrics system in the AOptix exhibition booth at the upcoming Biometrics Consortium Conference and Technology Expo. The event takes place in Tampa from September 21 to 23, 2010.
Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmaceutical companies, today announced its financial results for the second quarter ended June 30, 2009.
› Verified 5 days ago